Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:28 AM
Ignite Modification Date:
2025-12-25 @ 2:28 AM
NCT ID:
NCT00106834
Eligibility Criteria:
Inclusion Criteria:
* Patients who have had a diagnosis of plaque-type psoriasis for at least 6 months
* Patients who have plaque-type psoriasis covering at least 10% of the body
Exclusion Criteria:
* Patients must not have nonplaque forms of psoriasis
* Patients must not have current drug-induced psoriasis
* Patients must not be pregnant, nursing, or planning pregnancy (both men and women) within 18 months of enrollment
* Patients must not have had any previous treatment with infliximab or any therapeutic agent targeted at reducing TNF
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00106834
Study Brief:
Protocol Section:
NCT00106834